Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01551836
What this trial is testing

At What Time Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed Formulations

Who this might be right for
Healthy Volunteer
GlaxoSmithKline 12
Not applicableStudy completedNCT05602571
What this trial is testing

The Effectiveness of the Combination of PRP and ESWT in Lateral Epicondylitis

Who this might be right for
Musculoskeletal DiseasesElbow TendinitisLateral Epicondylitis+1 more
Afyonkarahisar Health Sciences University 91
Testing effectiveness (Phase 2)Study completedNCT01816971
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
University of Chicago 76
Large-scale testing (Phase 3)Ended earlyNCT02145598
What this trial is testing

Treatment Optimization in Patients With Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dr. med. Lars-Olof Muegge 85
Testing effectiveness (Phase 2)Looking for participantsNCT06107738
What this trial is testing

Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Barbara Ann Karmanos Cancer Institute 60
Not applicableNot Yet RecruitingNCT05483634
What this trial is testing

Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause

Who this might be right for
MenopausePlatelet-rich PlasmaEstrogen Replacement Therapy+1 more
Mackay Memorial Hospital 40
Large-scale testing (Phase 3)Ended earlyNCT04502472
What this trial is testing

Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma

Who this might be right for
Covid-19
Inova Health Care Services 109
Early research (Phase 1)Study completedNCT01290965
What this trial is testing

Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Scynexis, Inc. 57
Not applicableUnknownNCT01615302
What this trial is testing

Is the Use of Blood Platelets Effective in the Treatment of Difficult Fistulas Related to the Anal Sphincter?

Who this might be right for
Rectal Fistula
Maastricht University Medical Center 120
Early research (Phase 1)Active Not RecruitingNCT04754945
What this trial is testing

Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis

Who this might be right for
AL Amyloidosis
Emory University 11
Very early researchUnknownNCT03661554
What this trial is testing

BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
The Pregene (ShenZhen) Biotechnology Company, Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT04750837
What this trial is testing

Platelet Rich Plasma and Diabetic Foot Ulcer

Who this might be right for
Platelet Rich Plasma
Zagazig University 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT05801939
What this trial is testing

Cevostamab Following CAR T Cell Therapy for RRMM

Who this might be right for
Relapsed/Refractory Multiple Myeloma
University of Pennsylvania 30
Not applicableLooking for participantsNCT03375619
What this trial is testing

Long-term Follow-up Study of Patients Receiving CAR-T Cells

Who this might be right for
Chronic Lymphocytic LeukemiaLymphomas Non-Hodgkin's B-CellLymphoma, Small Lymphocytic+6 more
Medical College of Wisconsin 500
Large-scale testing (Phase 3)UnknownNCT05006469
What this trial is testing

Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma

Who this might be right for
BendamustineMultiple Myeloma
Liao Aijun 10
Testing effectiveness (Phase 2)Looking for participantsNCT04776395
What this trial is testing

Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
Emory University 68
Large-scale testing (Phase 3)UnknownNCT03428373
What this trial is testing

Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma ProgressionMultiple Myeloma Stage II+3 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 57
Large-scale testing (Phase 3)Ended earlyNCT05271929
What this trial is testing

Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19

Who this might be right for
COVID-19
Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen 120
Very early researchUnknownNCT06067581
What this trial is testing

The Safety and Efficacy of SENL103 Autologous T Cell Injection

Who this might be right for
Multiple Myeloma
Hebei Senlang Biotechnology Inc., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT06235229
What this trial is testing

GC012F in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Gracell Biotechnologies (Shanghai) Co., Ltd. 110
Next Page